Role of Androgen Receptors as a Prognostic and Predictive Biomarker in Triple-Negative Breast Cancer Sameer RastogiBhawna Sirohi Invited Commentary 30 September 2015 Pages: 171 - 174
The Cyclin D/Cyclin-dependent Kinase 4/6 Complex as a Target in the Treatment of Breast Cancer Amy S. ClarkAngela DeMichele Clinical Trials (S Hurvitz, Section Editor) 26 August 2015 Pages: 175 - 182
Adjuvant Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer in Premenopausal Patient: Understanding the Data Poornima SahaGini F. Fleming Clinical Trials (S Hurvitz, Section Editor) 14 September 2015 Pages: 183 - 189
Optimizing the Management of Metastatic HER2-Positive Breast Cancer Shom GoelSara Tolaney Clinical Trials (S Hurvitz, Section Editor) 15 September 2015 Pages: 190 - 202
Targeting the Immune System in Breast Cancer: Hype or Hope?: TILs and Newer Immune-Based Therapies Being Evaluated for HER2+ and TNBC Sibylle LoiblJenny Furlanetto Clinical Trials (S Hurvitz, Section Editor) 30 September 2015 Pages: 203 - 209
Clinical Implications of Mutations in the PI3K Pathway in HER2+ Breast Cancer: Prognostic or Predictive? Ingrid A. Mayer Clinical Trials (S Hurvitz, Section Editor) 10 October 2015 Pages: 210 - 214
Potential Therapeutic Targets in Triple Negative Breast Cancer Hamdy A. AzimHatem A. Azim Jr. Biomarkers (S Dawood, Section Editor) 23 September 2015 Pages: 215 - 223
Emerging Predictive Biomarkers of Response to Platinum Therapy in Triple-Negative Breast Cancer Michal MegoJames M. Reuben Biomarkers (S Dawood, Section Editor) 01 October 2015 Pages: 224 - 231
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer Koo Si-LinLoh KileyYap Yoon Sim Biomarkers (S Dawood, Section Editor) 28 October 2015 Pages: 232 - 241